DeepSummary
In this podcast episode, host Colleen McDonald interviews Dr. Joanne Welsh, an expert in immunology and vaccine development, to better understand the process of creating a vaccine, particularly in the context of the ongoing COVID-19 pandemic. Dr. Welsh explains the basic premise of vaccines, which is to stimulate the body's immune system to produce antibodies against a specific pathogen, allowing it to be better prepared to fight off future infections.
Dr. Welsh goes on to describe the typical step-by-step process of vaccine development, which includes identifying the target pathogen, testing potential vaccine candidates in animal models, conducting clinical trials to assess safety and efficacy, and finally seeking regulatory approval for widespread use. She highlights that the process is often slow and painstaking, with a significant failure rate at each stage.
In the case of the COVID-19 vaccine, Dr. Welsh notes that the process has been accelerated due to the urgency of the situation and the sharing of genetic data among researchers worldwide. However, she emphasizes that the same rigorous safety and efficacy standards must still be met, and cautions against unrealistic public expectations for an immediate solution.
Key Episodes Takeaways
- Vaccine development is a complex and time-consuming process, involving multiple stages of research, testing, and clinical trials.
- Modern vaccine development often relies on genomic sequencing and targeting specific viral or bacterial proteins.
- The COVID-19 vaccine development process has been accelerated due to the urgency of the pandemic, but still requires rigorous safety and efficacy testing.
- There is a significant failure rate at each stage of vaccine development, and no guarantee of success.
- Therapeutic treatments for COVID-19 may be available sooner than a vaccine, but also require extensive testing and validation.
- Public expectations for a rapid COVID-19 vaccine solution should be tempered, as the development process typically takes years.
- Collaboration and data-sharing among researchers worldwide are crucial for expediting vaccine development efforts.
- The same regulatory standards and clinical trial protocols must be followed, even in the case of the COVID-19 pandemic.
Top Episodes Quotes
- “It's a very, usually slow and painstaking process. I think that the first thing you do is learn the most you can about the pathogen, and then you isolate that target, and then you create in the lab a formulation like, let's say it's a polysaccharide that covers the surface of the bacteria.“ by Joanne Welsh
- “The basic premise of a vaccine is that you are going to make a really safe, an effective vaccine. That when you administer it to an individual, a healthy individual, that you are going to get your body, your immune system, to make antibodies to, usually a protein or sometimes a polysaccharide.“ by Joanne Welsh
- “I think that now we really go straight to the genome. We get the sequence, we figure out what's important, and you have to actually go through and really know the biology of the pathogen and understand what the critical proteins are that that virus makes so that you can target that.“ by Joanne Welsh
- “I don't think we can presume that there is going to be a vaccine around the corner. It's much more likely that we will have a therapeutic, like a drug that we can use to treat patients much faster. But even then, drug therapeutic, it will be a few months away because we need to make sure that it is actually working.“ by Joanne Welsh
Entities
Product
Organization
Book
Disease
Person
Episode Information
Got Science?
KKFI Community Podcasts
3/31/20